Literature DB >> 21450528

Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome.

Li-Li Liu1, Yan Qin, Jian-Fang Cai, Hai-Yun Wang, Jian-Ling Tao, Hang Li, Li-Meng Chen, Ming-Xi Li, Xue-Mei Li, Xue-Wang Li.   

Abstract

To determine whether Th17/Treg balance was abnormal in adult patients with minimal change nephrotic syndrome (MCNS), we studied 25 patients with new-onset MCNS and 20 normal persons. The results showed that MCNS patients exhibited a significant increase in Th17 number, Th17-related cytokines (IL-17 and IL-23), and transcription factor (RORγt) levels, as well as an obvious decrease in Treg number, Treg-related cytokines (TGF-β1 and IL-10), and transcription factor (Foxp3) levels. The Th17/Treg ratios increased along with increased proteinuria and decreased albumin levels in patients with MCNS. IL-17 protein expression was also detected in the renal biopsy tissue of MCNS patients, particularly in patients with acute renal failure. Further, Th17/Treg balance returned to normal after effective corticosteroids therapy in 16 MCNS patients. These results indicated that Th17/Treg imbalance existed in MCNS patients, suggesting a potential role of Th17/Treg imbalance in the pathogenesis of MCNS.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450528     DOI: 10.1016/j.clim.2011.02.018

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  46 in total

1.  Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.

Authors:  Si Ai; Jian Zheng; Qing Lin; Rongyan Chen
Journal:  Clin Exp Nephrol       Date:  2012-07-07       Impact factor: 2.801

2.  Busy Bs.

Authors:  Howard Trachtman
Journal:  J Am Soc Nephrol       Date:  2015-11-30       Impact factor: 10.121

3.  Development of minimal-change glomerular disease and Hashimoto's thyroiditis during the treatment of sarcoidosis.

Authors:  Fumiaki Ando; Tomokazu Okado; Eisei Sohara; Tatemitsu Rai; Shinichi Uchida; Sei Sasaki
Journal:  CEN Case Rep       Date:  2013-03-17

Review 4.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

5.  Alterations of immune cell subsets in relapsed, thymoma-associated minimal change disease: A case report.

Authors:  Helen Gharwan; Yusuke Tomita; Min-Jung Lee; Anish Thomas; Arlene Berman; Giuseppe Giaccone; Jane Trepel; Arun Rajan
Journal:  Oncol Lett       Date:  2015-06-05       Impact factor: 2.967

6.  Calcium channel Orai1 promotes lymphocyte IL-17 expression and progressive kidney injury.

Authors:  Purvi Mehrotra; Michael Sturek; Javier A Neyra; David P Basile
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

7.  Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.

Authors:  Pietro Ravani; Roberta Rossi; Alice Bonanni; Robert R Quinn; Felice Sica; Monica Bodria; Andrea Pasini; Giovanni Montini; Alberto Edefonti; Mirco Belingheri; Donatella De Giovanni; Giancarlo Barbano; Ludovica Degl'Innocenti; Francesco Scolari; Luisa Murer; Jochen Reiser; Alessia Fornoni; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2015-01-15       Impact factor: 10.121

Review 8.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

9.  MicroRNA-155 deficiency promotes nephrin acetylation and attenuates renal damage in hyperglycemia-induced nephropathy.

Authors:  Xu Lin; Yanwu You; Jie Wang; Youling Qin; Peng Huang; Fafen Yang
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 10.  Rituximab therapy in nephrotic syndrome: implications for patients' management.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.